ATIP vs. CPIX, XGN, ALRN, LSTA, ABIO, APRE, CDIO, UBX, BIVI, and SABS
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Cumberland Pharmaceuticals (CPIX), Exagen (XGN), Aileron Therapeutics (ALRN), Lisata Therapeutics (LSTA), ARCA biopharma (ABIO), Aprea Therapeutics (APRE), Cardio Diagnostics (CDIO), Unity Biotechnology (UBX), BioVie (BIVI), and SAB Biotherapeutics (SABS). These companies are all part of the "medical" sector.
Cumberland Pharmaceuticals (NASDAQ:CPIX) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends.
Cumberland Pharmaceuticals received 172 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 45.72% of users gave Cumberland Pharmaceuticals an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
ATI Physical Therapy has a net margin of -9.98% compared to ATI Physical Therapy's net margin of -15.87%. ATI Physical Therapy's return on equity of 6.84% beat Cumberland Pharmaceuticals' return on equity.
Cumberland Pharmaceuticals has higher earnings, but lower revenue than ATI Physical Therapy. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.
15.5% of Cumberland Pharmaceuticals shares are owned by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are owned by institutional investors. 43.3% of Cumberland Pharmaceuticals shares are owned by company insiders. Comparatively, 0.9% of ATI Physical Therapy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Cumberland Pharmaceuticals had 31 more articles in the media than ATI Physical Therapy. MarketBeat recorded 32 mentions for Cumberland Pharmaceuticals and 1 mentions for ATI Physical Therapy. Cumberland Pharmaceuticals' average media sentiment score of 1.00 beat ATI Physical Therapy's score of -0.15 indicating that ATI Physical Therapy is being referred to more favorably in the news media.
Cumberland Pharmaceuticals has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500.
Summary
Cumberland Pharmaceuticals beats ATI Physical Therapy on 9 of the 15 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ATI Physical Therapy Competitors List
Related Companies and Tools